DuPont and ADM open world-first FDME pilot production facility
Submitted by:
Andrew Warmington
DuPont Industrial Biosciences and Archer Daniels Midland Company (ADM) have opened the world’s first biobased
EU votes to ban neonicotinoids
Submitted by:
Andrew Warmington
EU member states have voted to impose a near- total ban on neonicotinoid insecticides –
Takeda and Shire settle on US$62 billion deal
Submitted by:
Andrew Warmington
After months of discussions, Japan’s Takeda Pharmaceutical Company has reached an agreement to acquire Shire
Madison Dearborn Partners to acquire Alcami
Submitted by:
Andrew Warmington
Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology
DCAT awards scholarships for astonishing student projects
Submitted by:
Andrew Warmington
The Drug, Chemical & Associated Technologies Association (DCAT) has announced the winners of four scholarships
CPhI: Science fiction and innovation
Submitted by:
Andrew Warmington
This year’s InformEx/CPhI North America event was buzzing, with thousands of attendees and over 25
There are two fundamental questions in healthcare, Leist said: “Did the patient take their medicine
AkzoNobel to sell speciality chemicals business for €10 billion
Submitted by:
Andrew Warmington
Paints, coatings and speciality chemicals multinational AkzoNobel has announced the sale of its entire speciality chemicals
Evonik and Siemens join up to produce 'green' speciality chemicals
Submitted by:
Andrew Warmington
Chemicals company Evonik and electronics giant Siemens have launched a joint research project to convert
EU clears way for Bayer, Monsanto mega-merger
Submitted by:
Andrew Warmington
Agrichemical giant Bayer has won EU antitrust approval for its US$62.5 billion acquisition of Monsanto,
Lonza cuts ribbon on world’s largest cell and gene therapy facility
Submitted by:
Andrew Warmington
Lonza has opened the world’s largest dedicated cell and gene therapy manufacturing facility in Houston, Texas